Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline Demographics and Clinical Characteristics in the All Nippon AF in the Elderly (ANAFIE) Registry.
Koretsune Y, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, Shimizu W, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Kaburagi J, Takita A, Inoue H. Koretsune Y, et al. Among authors: hirayama a. Circ J. 2019 Jun 25;83(7):1538-1545. doi: 10.1253/circj.CJ-19-0094. Epub 2019 Jun 5. Circ J. 2019. PMID: 31168044 Free article. Clinical Trial.
Circadian variation of the onset of acute myocardial infarction in the Osaka area, 1998-1999: characterization of morning and nighttime peaks.
Kinjo K, Sato H, Sato H, Shiotani I, Kurotobi T, Ohnishi Y, Hishida E, Nakatani D, Ito H, Koretsune Y, Hirayama A, Tanouchi J, Mishima M, Kuzuya T, Takeda H, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Kinjo K, et al. Among authors: hirayama a. Jpn Circ J. 2001 Jul;65(7):617-20. doi: 10.1253/jcj.65.617. Jpn Circ J. 2001. PMID: 11446494 Free article.
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E; J-RHYTHM II Investigators. Yamashita T, et al. Among authors: hirayama a. Circ J. 2006 Oct;70(10):1318-21. doi: 10.1253/circj.70.1318. Circ J. 2006. PMID: 16998266 Free article. Clinical Trial.
Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction.
Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, Ito H, Koretsune Y, Hirayama A, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Nakatani D, et al. Among authors: hirayama a. Am J Cardiol. 2007 Apr 1;99(7):885-9. doi: 10.1016/j.amjcard.2006.11.033. Epub 2007 Feb 12. Am J Cardiol. 2007. PMID: 17398177
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study.
Sato H, Kinjo K, Ito H, Hirayama A, Nanto S, Fukunami M, Nishino M, Lim YJ, Kijima Y, Koretsune Y, Nakatani D, Mizuno H, Shimizu M, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS)-LIPID Study Investigators. Sato H, et al. Among authors: hirayama a. Circ J. 2008 Jan;72(1):17-22. doi: 10.1253/circj.72.17. Circ J. 2008. PMID: 18159093 Free article. Clinical Trial.
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S; J-RHYTHM II Investigators. Yamashita T, et al. Among authors: hirayama a. Europace. 2011 Apr;13(4):473-9. doi: 10.1093/europace/euq439. Epub 2010 Dec 10. Europace. 2011. PMID: 21148662 Clinical Trial.
Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
Kinugawa K, Nagai R, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, Hori M; J-Land Investigators. Kinugawa K, et al. Adv Ther. 2014 Apr;31(4):426-39. doi: 10.1007/s12325-014-0111-2. Epub 2014 Mar 19. Adv Ther. 2014. PMID: 24643403 Free PMC article. Clinical Trial.
Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
Saito Y, Watanabe M, Aonuma K, Hirayama A, Tamaki N, Tsutsui H, Murohara T, Ogawa H, Akasaka T, Yoshimura M, Sato A, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K; CINC-J study investigators. Saito Y, et al. Among authors: hirayama a. Circ J. 2015;79(7):1624-30. doi: 10.1253/circj.CJ-14-1345. Epub 2015 Apr 17. Circ J. 2015. PMID: 25891891 Free article. Clinical Trial.
Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, Toyoaki M, Ogawa H, Akasaka T, Yoshimura M, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, Saito Y; CINC-J study investigators. Sato A, et al. Among authors: hirayama a. Int J Cardiol. 2017 Jan 15;227:424-429. doi: 10.1016/j.ijcard.2016.11.019. Epub 2016 Nov 7. Int J Cardiol. 2017. PMID: 27838134
1,384 results